Drugs & Aging

, Volume 36, Issue 2, pp 155–163 | Cite as

Discrepancy Between Equations Estimating Kidney Function in Geriatric Care: A Study of Implications for Drug Prescription

  • Florent GuervilleEmail author
  • Claire Roubaud-Baudron
  • Sophie Duc
  • Nathalie Salles
  • Muriel Rainfray
  • Isabelle Bourdel-Marchasson
Short Communication



In older patients, the agreement is low between creatinine clearance estimated with the Cockcroft-Gault equation (eCrCl) and glomerular filtration rate estimated with the Chronic Kidney Disease Epidemiology Collaboration equation (eGFRCKD-EPI). The implications of these discrepancies for drug prescription have so far been assessed only for a few selected molecules.


The aim of this study was to investigate the proportion of geriatric patients receiving drugs with a different recommended dose or indication (i.e. an adjustment discrepancy) depending on eCrCl versus eGFRCKD-EPI estimates of kidney function.


Patients admitted to acute geriatric care units in our university hospital were eligible for inclusion. All drug classes were studied. We retrospectively determined recommended prescriptions according to eCrCl and eGFRCKD-EPI.


Sixty percent of patients received at least one drug requiring dose adjustment and/or received a drug with a relative contraindication based on their estimated kidney function. Thirty-one percent of patients received at least one drug with an adjustment discrepancy: 20% received at least one drug for which the recommended dose differed depending on eCrCl versus eGFRCKD-EPI estimates of kidney function, 4% received a drug with a relative contraindication according to eCrCl but not eGFRCKD-EPI, and 7% received both. Factors independently associated with an adjustment discrepancy were older age and lower weight. Main drug classes involved were benzodiazepines, anticoagulants, and anti-microbial drugs.


In acute geriatric care units, recommended drug dose adjustments are frequently discordant according to the equations used to estimate kidney function, notably for benzodiazepines, anticoagulants, and anti-microbial drugs. The consequences for treatment efficacy and safety should be investigated.


Compliance with Ethical Standards


No sources of funding were used to assist in the conduct of this study or the preparation of this article.

Conflict of Interest

Florent Guerville, Claire Roubaud-Baudron, Sophie Duc, Nathalie Salles, Muriel Rainfray and Isabelle Bourdel-Marchasson declare that they have no conflicts of interest relevant to the content of this study.

Ethical approval

This study was conducted in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. The database has been anonymized and protected. In view of the material available to it, our institutional ethics committee issued a favorable opinion for the publication of this research work (decision #CE-GP-2018/14).

Supplementary material

40266_2018_618_MOESM1_ESM.pdf (88 kb)
Electronic Supplementary Material Fig. S1. Comparison of Chronic Kidney Disease Epidemiology Collaboration-estimated glomerular filtration rate and Cockcroft-Gault-estimated creatinine clearance. Bland-Altman comparison of Chronic Kidney Disease Epidemiology Collaboration equation-based estimated glomerular filtration rate (eGFRCKD-EPI) and Cockcroft-Gault equation-based estimated creatinine clearance (eCrCl) at admission. Mean difference between results of the two equations (solid black line) ± 2 standard deviations (dashed black lines). Black dots represent patients receiving at least one drug whose recommended prescription (dose or contraindication) was different according to eCrCl and eGFRCKD-EPI adjustment. White dots represent patients receiving drugs whose recommended prescription was the same according to eCrCl and eGFRCKD-EPI. Difference (Y-axis) and mean (X-axis) of the two equation results were not correlated using a linear regression (r2 = 0.001, p = 0.7) (PDF 88 kb)
40266_2018_618_MOESM2_ESM.pptx (94 kb)
Supplementary material 2 (PPTX 94 kb)


  1. 1.
    Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.CrossRefGoogle Scholar
  2. 2.
    Stengel B, Metzger M, Froissart M, Rainfray M, Berr C, Tzourio C, et al. Epidemiology and prognostic significance of chronic kidney disease in the elderly–the Three-City prospective cohort study. Nephrol Dial Transplant. 2011;26(10):3286–95.CrossRefGoogle Scholar
  3. 3.
    Grams ME, Chow EKH, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013;62(2):245–52.CrossRefGoogle Scholar
  4. 4.
    Matzke GR, Comstock T. Influence of renal disease and dialysis on pharmacokinetics. Appl Pharmacokinet Princ Ther Drug Monit 4th Edn Lippincott Williams Wilkens Baltim MD. 2005;187–212.Google Scholar
  5. 5.
    Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function–the Three-City population-based study. Nephrol Dial Transpl. 2011;26(9):2852–9.CrossRefGoogle Scholar
  6. 6.
    Budnitz DS, Lovegrove MC, Shehab Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–12.CrossRefGoogle Scholar
  7. 7.
    Mühlberg W, Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology. 1999;45(5):243–53.CrossRefGoogle Scholar
  8. 8.
    Kurtal H, Schwenger V, Azzaro M, Abdollahnia N, Steinhagen-Thiessen E, Nieczaj R, et al. Clinical value of automatic reporting of estimated glomerular filtration rate in geriatrics. Gerontology. 2009;55(3):288–95.CrossRefGoogle Scholar
  9. 9.
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.CrossRefGoogle Scholar
  10. 10.
    Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604.CrossRefGoogle Scholar
  11. 11.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461–70.CrossRefGoogle Scholar
  12. 12.
    Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group—a cautionary tale. Nephrol Dial Transplant. 2007;22(10):2894–9.CrossRefGoogle Scholar
  13. 13.
    Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–9.CrossRefGoogle Scholar
  14. 14.
    Farrington K, Covic A, Aucella F, Clyne N, de Vos L, Findlay A, et al. Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR< 45 mL/min/1.73 m2). Nephrol Dial Transplant. 2016;31(suppl 2):ii1–ii66.CrossRefGoogle Scholar
  15. 15.
    KDIGO. Clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2(1):8–12.CrossRefGoogle Scholar
  16. 16.
    Flamant M, Haymann J-P, Vidal-Petiot E, Letavernier E, Clerici C, Boffa JJ, et al. GFR estimation using the Cockcroft-Gault, MDRD study, and CKD-EPI equations in the elderly. Am J Kidney Dis. 2012;60(5):847–9.CrossRefGoogle Scholar
  17. 17.
    Evaluation du débit de filtration glomérulaire et du dosage de la créatininémie dans le diagnostic de maladie rénale chronique chez l’adulte. Haute Autorité de Santé (French). 2016. Accessed 10 Oct 2016.
  18. 18.
    Dowling TC, Matzke GR, Murphy JE, Burckart GJ. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy. 2010;30(8):776–86.CrossRefGoogle Scholar
  19. 19.
    MacCallum PK, Mathur R, Hull SA, Saja K, Green L, Morris JK, et al. Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study. BMJ Open. 2013;3(9):e003343.CrossRefGoogle Scholar
  20. 20.
    Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16(3):763–73.CrossRefGoogle Scholar
  21. 21.
    Gouin-Thibault I, Pautas E, Mahé I, Descarpentries C, Nivet-Antoine V, Golmard JL, et al. Is modification of diet in renal disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin? J Gerontol A Biol Sci Med Sci. 2007;62(11):1300–5.CrossRefGoogle Scholar
  22. 22.
    Dowling TC, Wang E-S, Ferrucci L, Sorkin JD. Glomerular filtration rate equations overestimate creatinine clearance in elder individuals enrolled in the Baltimore longitudinal study on aging: impact on renal drug dosing. Pharmacother J Hum Pharmacol Drug Ther. 2013;33(9):912–21.CrossRefGoogle Scholar
  23. 23.
    Helldén A, Odar-Cederlöf I, Nilsson G, Sjöviker S, Söderström A, von Euler M, et al. Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly. BMJ Open. 2013;3(4):e002686.CrossRefGoogle Scholar
  24. 24.
    KDIGO. Clinical practice guidelines for acute kidney injury. Kidney Int Suppl. 2013;3(1):5–14.CrossRefGoogle Scholar
  25. 25.
    Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;21(185):914–9.CrossRefGoogle Scholar
  26. 26.
    Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.CrossRefGoogle Scholar
  27. 27.
    Du Bois D, Du Bois E. A formula to estimate the approximate surface area if weight and height be known. Arch Intern Med. 1916;17:863–71.CrossRefGoogle Scholar
  28. 28.
    Matzke GR, Aronoff GR, Atkinson AJ Jr, Bennett WM, Decker BS, Eckardt KU, et al. Drug dosing consideration in patients with acute and chronic kidney disease - a clinical update from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2011;80(11):1122–37.CrossRefGoogle Scholar
  29. 29.
    SiteGPR. 2016. Accessed 10 Oct 2016.
  30. 30.
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.CrossRefGoogle Scholar
  31. 31.
    Bolek T, Samoš M, Škorňová I, Stančiaková L, Staško J, Galajda P, et al. Dabigatran levels in elderly patients with atrial fibrillation: first post-marketing experiences. Drugs Aging. 2018;35(6):539–44.CrossRefGoogle Scholar
  32. 32.
    Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10(4):193–207.CrossRefGoogle Scholar
  33. 33.
    Corsonello A, Pedone C, Lattanzio F, Onder G, Antonelli Incalzi R. Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients. Drugs Aging. 2011;28(5):379–90.CrossRefGoogle Scholar
  34. 34.
    Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R, et al. Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant. 2010;25(2):449–57.CrossRefGoogle Scholar
  35. 35.
    Helldén A, Bergman U, von Euler M, Hentschke M, Odar-Cederlöf I, Öhlén G. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department. Drugs Aging. 2009;26(7):595–606.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.CHU Bordeaux, Département de Gérontologie CliniquePessacFrance
  2. 2.Univ. BordeauxBordeauxFrance
  3. 3.Univ. Bordeaux, CNRS UMR 5536 RMSBBordeauxFrance

Personalised recommendations